MeiraGTx grants 100,000 RSUs to its CMO

MeiraGTx Holdings plc granted its Chief Medical Officer, Robert K. Zeldin, 100,000 restricted share units (RSUs).

Rhea-AI Filing Summary

MeiraGTx Holdings plc granted its Chief Medical Officer, Robert K. Zeldin, 100,000 restricted share units (RSUs). Each RSU converts into one ordinary share upon vesting, so the award represents 100,000 underlying ordinary shares.

According to the vesting schedule, 50% of the RSUs will vest on the second anniversary of the grant date, with an additional 25% vesting on each of the third and fourth anniversaries. Following this grant, Zeldin is reported as holding 100,000 RSUs directly.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Zeldin Robert K

Role CHIEF MEDICAL OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	100,000	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 100,000 contracts (Direct)

Footnotes (2)

1. F1. Each restricted share unit converts into one ordinary share upon vesting.
2. F2. Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.

Key Figures

RSUs granted: 100,000 RSUs Underlying ordinary shares: 100,000 shares Post-grant RSU holdings: 100,000 RSUs +3 more

6 metrics

RSUs granted 100,000 RSUs Grant to Chief Medical Officer on 2026-06-25

Underlying ordinary shares 100,000 shares Each RSU converts into one ordinary share upon vesting

Post-grant RSU holdings 100,000 RSUs Total RSUs reported following the transaction

Vesting at second anniversary 50% of award Portion of RSUs vesting on second anniversary of grant date

Vesting at third anniversary 25% of award Portion of RSUs vesting on third anniversary of grant date

Vesting at fourth anniversary 25% of award Portion of RSUs vesting on fourth anniversary of grant date

Key Terms

Restricted Share Units, vesting, Ordinary Shares

3 terms

Restricted Share Units financial

"Each restricted share unit converts into one ordinary share upon vesting."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

vesting financial

"Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Ordinary Shares financial

"Each restricted share unit converts into one ordinary share upon vesting."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MeiraGTx (MGTX) disclose in this Form 4 filing?

MeiraGTx disclosed that Chief Medical Officer Robert K. Zeldin received a grant of 100,000 restricted share units. These RSUs are a form of equity compensation that can convert into ordinary shares over time as they vest under the specified schedule.

How many restricted share units did MeiraGTx’s CMO receive in this grant?

Robert K. Zeldin received 100,000 restricted share units. Each restricted share unit is designed to convert into one ordinary share upon vesting, meaning the award represents potential ownership of 100,000 MeiraGTx ordinary shares if all vesting conditions are ultimately satisfied.

What is the vesting schedule for the 100,000 MeiraGTx RSUs granted to the CMO?

The award vests over four years from the grant date. Fifty percent of the restricted share units vest on the second anniversary, and an additional twenty-five percent vest on each of the third and fourth anniversaries, creating a multi-year retention incentive for the executive.

How do the MeiraGTx RSUs convert into ordinary shares for the CMO?

Each restricted share unit converts into one ordinary share of MeiraGTx upon vesting. This means that as portions of the award vest over time, the executive becomes entitled to receive an equivalent number of ordinary shares, aligning compensation with long-term company performance.

What is the CMO’s reported RSU position after this MeiraGTx grant?

Following this grant, the Form 4 reports that Robert K. Zeldin holds 100,000 restricted share units directly. This reflects the full amount of the current award, which will convert into ordinary shares only as the vesting milestones are reached in future years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 09:19 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zeldin Robert K

(Last) (First) (Middle)

655 THIRD AVENUE

SUITE 1115

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF MEDICAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	06/25/2026		A		100,000		(2)	(2)	Ordinary Shares	100,000	$0	100,000	D

Explanation of Responses:

1. Each restricted share unit converts into one ordinary share upon vesting.

2. Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.

	/s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)